Iloperidone and VHX-896

DRUG2 trials

Sponsors

Vanda Pharmaceuticals

Conditions

Bipolar I DisorderHealthySchizophrenia

Phase 1

Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers

CompletedNCT04969211

Vanda PharmaceuticalsHealthy

Start: 2021-06-30End: 2021-10-13Updated: 2022-07-11

Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions

CompletedNCT06494397

Vanda PharmaceuticalsBipolar I Disorder, Schizophrenia

Start: 2024-07-11End: 2024-10-24Updated: 2025-09-19